vs
Astrana Health, Inc.（ASTH）とLoews Corporation（L）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $827.0M、Loews Corporationの約1.1倍）。Loews Corporationの純利益率が高く（48.6% vs 0.7%、差は47.9%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 4.8%）。Loews Corporationの直近四半期フリーキャッシュフローが多い（$426.0M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 7.9%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
ローズ・コーポレーションは米国を本拠地とする多角的コングロマリットで、子会社を通じて損害保険、天然ガスパイプライン輸送、ホテル運営、石油・ガス探鉱生産の各事業を展開し、主に北米市場の商業顧客、一般消費者、産業顧客向けにサービスを提供している。
ASTH vs L — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $827.0M |
| 純利益 | $6.6M | $402.0M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 65.4% |
| 純利益率 | 0.7% | 48.6% |
| 売上前年比 | 42.9% | 4.8% |
| 純利益前年比 | 184.4% | 115.0% |
| EPS（希薄化後） | $0.12 | $1.93 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $827.0M | ||
| Q3 25 | $956.0M | $732.0M | ||
| Q2 25 | $654.8M | $769.0M | ||
| Q1 25 | $620.4M | $846.0M | ||
| Q4 24 | $665.2M | $789.0M | ||
| Q3 24 | $478.7M | $683.0M | ||
| Q2 24 | $486.3M | $711.0M | ||
| Q1 24 | $404.4M | $710.0M |
| Q4 25 | $6.6M | $402.0M | ||
| Q3 25 | $373.0K | $504.0M | ||
| Q2 25 | $9.4M | $391.0M | ||
| Q1 25 | $6.7M | $370.0M | ||
| Q4 24 | $-7.8M | $187.0M | ||
| Q3 24 | $16.1M | $401.0M | ||
| Q2 24 | $19.2M | $369.0M | ||
| Q1 24 | $14.8M | $457.0M |
| Q4 25 | 1.9% | 65.4% | ||
| Q3 25 | 2.0% | 94.1% | ||
| Q2 25 | 3.1% | 70.1% | ||
| Q1 25 | 3.3% | 60.8% | ||
| Q4 24 | 0.1% | 23.8% | ||
| Q3 24 | 5.9% | 80.5% | ||
| Q2 24 | 6.2% | 71.3% | ||
| Q1 24 | 7.5% | 88.6% |
| Q4 25 | 0.7% | 48.6% | ||
| Q3 25 | 0.0% | 68.9% | ||
| Q2 25 | 1.4% | 50.8% | ||
| Q1 25 | 1.1% | 43.7% | ||
| Q4 24 | -1.2% | 23.7% | ||
| Q3 24 | 3.4% | 58.7% | ||
| Q2 24 | 3.9% | 51.9% | ||
| Q1 24 | 3.7% | 64.4% |
| Q4 25 | $0.12 | $1.93 | ||
| Q3 25 | $0.01 | $2.43 | ||
| Q2 25 | $0.19 | $1.87 | ||
| Q1 25 | $0.14 | $1.74 | ||
| Q4 24 | $-0.14 | $0.87 | ||
| Q3 24 | $0.33 | $1.82 | ||
| Q2 24 | $0.40 | $1.67 | ||
| Q1 24 | $0.31 | $2.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $6.0B |
| 総負債低いほど良い | — | $8.4B |
| 株主資本純資産 | $779.3M | $18.7B |
| 総資産 | $2.2B | $86.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.45× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $6.0B | ||
| Q3 25 | $463.4M | $5.4B | ||
| Q2 25 | $342.1M | $4.5B | ||
| Q1 25 | $260.9M | $4.4B | ||
| Q4 24 | $290.8M | $4.6B | ||
| Q3 24 | $350.3M | $5.2B | ||
| Q2 24 | $327.7M | $4.9B | ||
| Q1 24 | $337.3M | $5.4B |
| Q4 25 | — | $8.4B | ||
| Q3 25 | — | $8.4B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $8.4B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.8B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.4B |
| Q4 25 | $779.3M | $18.7B | ||
| Q3 25 | $775.5M | $18.3B | ||
| Q2 25 | $765.5M | $17.5B | ||
| Q1 25 | $745.4M | $17.2B | ||
| Q4 24 | $712.7M | $17.1B | ||
| Q3 24 | $704.6M | $17.4B | ||
| Q2 24 | $678.9M | $16.4B | ||
| Q1 24 | $653.5M | $16.2B |
| Q4 25 | $2.2B | $86.3B | ||
| Q3 25 | $2.2B | $85.9B | ||
| Q2 25 | $1.4B | $84.7B | ||
| Q1 25 | $1.3B | $83.1B | ||
| Q4 24 | $1.4B | $81.9B | ||
| Q3 24 | $1.3B | $83.6B | ||
| Q2 24 | $1.3B | $81.1B | ||
| Q1 24 | $1.2B | $80.9B |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.51× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.52× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $617.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $426.0M |
| FCFマージンFCF / 売上 | -0.6% | 51.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 23.1% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 1.53× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $2.7B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $617.0M | ||
| Q3 25 | $10.0M | $920.0M | ||
| Q2 25 | $90.9M | $1.0B | ||
| Q1 25 | $16.6M | $736.0M | ||
| Q4 24 | $-10.9M | $941.0M | ||
| Q3 24 | $34.0M | $934.0M | ||
| Q2 24 | $23.2M | $952.0M | ||
| Q1 24 | $6.0M | $198.0M |
| Q4 25 | $-6.0M | $426.0M | ||
| Q3 25 | $7.4M | $764.0M | ||
| Q2 25 | $89.5M | $872.0M | ||
| Q1 25 | $13.6M | $638.0M | ||
| Q4 24 | $-13.5M | $767.0M | ||
| Q3 24 | $31.7M | $794.0M | ||
| Q2 24 | $20.4M | $793.0M | ||
| Q1 24 | $5.6M | $39.0M |
| Q4 25 | -0.6% | 51.5% | ||
| Q3 25 | 0.8% | 104.4% | ||
| Q2 25 | 13.7% | 113.4% | ||
| Q1 25 | 2.2% | 75.4% | ||
| Q4 24 | -2.0% | 97.2% | ||
| Q3 24 | 6.6% | 116.3% | ||
| Q2 24 | 4.2% | 111.5% | ||
| Q1 24 | 1.4% | 5.5% |
| Q4 25 | 0.3% | 23.1% | ||
| Q3 25 | 0.3% | 21.3% | ||
| Q2 25 | 0.2% | 17.4% | ||
| Q1 25 | 0.5% | 11.6% | ||
| Q4 24 | 0.4% | 22.1% | ||
| Q3 24 | 0.5% | 20.5% | ||
| Q2 24 | 0.6% | 22.4% | ||
| Q1 24 | 0.1% | 22.4% |
| Q4 25 | -0.44× | 1.53× | ||
| Q3 25 | 26.69× | 1.83× | ||
| Q2 25 | 9.65× | 2.57× | ||
| Q1 25 | 2.48× | 1.99× | ||
| Q4 24 | — | 5.03× | ||
| Q3 24 | 2.11× | 2.33× | ||
| Q2 24 | 1.21× | 2.58× | ||
| Q1 24 | 0.40× | 0.43× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
L
| Transportation And Storage Of Natural Gas And NG Ls And Ethane Supply And Transportation Services | $601.0M | 73% |
| Lodging And Related Services | $226.0M | 27% |
